Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History $15.00 0.00 (0.00%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$15.00 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics Stock Price Performance The Cadrenal Therapeutics (CVKD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 3.52%. In the past month, the stock has increased 12.11%, reflecting recent market activity. As of the latest close, Cadrenal Therapeutics traded at $15.00 with a market cap of $29.51 million and volume of 12,715 shares. Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.66%1 Month Performance+12.11%3 Month Performance-15.11%Year-To-Date Performance+3.52% CVKD Stock Chart for Thursday, June, 12, 2025 CVKD Chart by TradingView Cadrenal Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$15.00$15.00$15.00$14.6312,715 shs$29.51 million06/10/2025$15.00$15.00$15.32$14.5723,792 shs$29.51 million06/09/2025$15.10$15.00-0.66%$15.50$14.8723,243 shs$29.51 million06/06/2025$14.61$15.10+3.35%$15.50$14.9023,719 shs$29.70 million06/05/2025$15.49$14.61-5.68%$15.68$14.4920,390 shs$28.74 million06/04/2025$13.69$15.49+13.15%$15.87$13.7066,055 shs$30.47 million06/03/2025$13.54$13.69+1.11%$13.69$13.2517,810 shs$26.93 million06/02/2025$13.34$13.54+1.50%$13.76$13.2519,344 shs$26.63 million05/30/2025$13.36$13.34-0.15%$13.59$13.2512,753 shs$26.24 million05/29/2025$13.93$13.36-4.09%$14.06$13.0016,688 shs$26.28 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$14.22$13.93-2.04%$14.46$13.7515,754 shs$27.40 million05/27/2025$14.75$14.22-3.59%$15.00$14.0116,916 shs$27.97 million05/26/2025$14.75$14.75$15.23$14.506,978 shs$29.01 million05/23/2025$15.03$14.75-1.86%$15.23$14.506,978 shs$29.01 million05/22/2025$15.70$15.03-4.27%$15.90$14.8010,459 shs$29.56 million05/21/2025$15.68$15.70+0.13%$15.85$15.089,300 shs$30.88 million05/20/2025$15.35$15.68+2.15%$15.74$14.9610,807 shs$30.84 million05/19/2025$15.50$15.35-0.97%$15.63$14.8013,307 shs$30.19 million05/16/2025$15.14$15.50+2.38%$16.25$15.1628,965 shs$30.49 million05/15/2025$14.14$15.14+7.07%$15.31$13.7630,757 shs$29.37 million05/14/2025$14.79$14.14-4.39%$14.67$13.5724,082 shs$27.43 million05/13/2025$13.38$14.79+10.54%$14.95$13.1044,773 shs$28.69 million05/12/2025$14.25$13.38-6.11%$15.83$13.2746,474 shs$25.96 million Related Companies CABA Stock Chart IMAB Stock Chart SAVA Stock Chart CRDL Stock Chart KRRO Stock Chart VIRI Stock Chart VXRT Stock Chart ADAG Stock Chart ORMP Stock Chart OPTN Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
